medetomidine has been researched along with tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickenson, AH; Kalso, EA; McQuay, HJ; Roques, BP; Sullivan, AF | 1 |
1 other study(ies) available for medetomidine and tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine
Article | Year |
---|---|
Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat.
Topics: Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Behavior, Animal; Drug Tolerance; Evoked Potentials; Imidazoles; Male; Medetomidine; Molecular Sequence Data; Morphine; Neurons; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Opioid, delta; Receptors, Opioid, mu; Spinal Cord | 1993 |